Close

Tag: Coronavirus information (COVID-19)

Geneius Develops Off-the-Shelf T Cell Therapy Targeting SARS-CoV-2

Geneius Biotechnology is developing T cells as a quasi-personalized, off-the-shelf, therapy and preventive measure against COVID-19. The assumption is that by increasing the number...

Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine Against Novel Coronavirus

Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients,...

Gilead’s drug remdesivir gets US FDA’s emergency use authorisation for COVID-19

Gilead was granted EUA by U.S. FDA for the investigational antiviral remdesivir to treat COVID-19. The EUA will facilitate broader use of remdesivir to...

Inspirata Hosts Fireside Chat on the Future of Pathology in a Post-COVID-19 World

Cancer informatics and digital pathology solution provider Inspirata is setting its sights on the post-COVID-19 future. Following the drastic social distancing measures implemented across the...

COVID-19 vaccine: key components are vital to a rapid response

As biopharmaceutical companies focus tirelessly on developing a vaccine for the COVID-19 virus, they are expected to both rapidly develop vaccines and then scale...

Hardy Diagnostics announces FDA EUA for antibody test and increases manufacturing capacity for COVID-19 products

Hardy Diagnostics, a medical device manufacturer based in Santa Maria, California, announced FDA EUA approval on April 24th for a new in vitro diagnostic...

ProteoGenix to accelerate the discovery of SARS-CoV-2 antibodies with first human immune COVID-19 library

ProteoGenix, a global leader in antibody production, is pleased to announce the first Human Immune COVID-19 library for the fast discovery of potent antibodies...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read